01—Abstract
Summary
Summary of the 8-K filed April 23, 2025. Cited figures are marked; the original filing is the authoritative source.
Texas Instruments reported first-quarter 2025 revenue of $4.07 billiona, up 11% year over year and 2% sequentially, with net income of $1.18 billion and diluted EPS of $1.28, up 7%.
Growth was led by Analog, where revenue rose 13%b and segment operating profit rose 20%. Embedded Processing revenue declined 1%, and its operating profit fell 62%. The EPS figure included a 5-cent benefit that was not in the original guidance, largely from discrete tax items.
Excluding that benefit, underlying earnings growth was more modest. The Q1 2024 comparison was also flattered by a $124 millionc restructuring credit and $129 million of asset-sale gains. Cash generation is the main point for investors to weigh.
Trailing-twelve-month cash flow from operations fell 2% to $6.15 billiond, while free cash flow rose 82% to $1.72 billion, helped by lower capital expenditures and $260 million of CHIPS Act incentive proceeds. Quarterly free cash flow was slightly negative at $(14) million, reflecting a $1.12 billion capex outlay and working-capital build, including a 15% year-over-year increase in inventories to $4.69 billion. Shareholder returns were substantial: $6.43 billion over the trailing twelve months, including $4.85 billion in dividends and $1.58 billion in buybacks, which together exceeded trailing free cash flow.
Management guided second-quarter revenue to $4.17–4.53 billion and EPS to $1.21–1.47, with an expected effective tax rate of 12–13%. The filing is a routine Item 2.02 earnings disclosure that furnishes the press release as Exhibit 99 and provides reconciliations for non-GAAP free cash flow.
Balance-sheet liquidity fell year over year, with cash and short-term investments of $5.0 billion versus $10.4 billion a year earlier, against long-term debt of $12.85 billion. Investors should monitor whether free cash flow can keep pace with dividends and buybacks as capex remains elevated.
02—Key points
Key Highlights
- Q1 2025 revenue of $4.07B grew 11% year over year and 2% sequentially; all markets grew sequentially except personal electronics, which declined seasonally.
- Diluted EPS of $1.28 rose 7% year over year but included a 5-cent benefit not in original guidance, largely from discrete tax items ($69M benefit in Q1 2025).
- Analog segment revenue rose 13% to $3.21B with operating profit up 20%, while Embedded Processing revenue fell 1% and operating profit dropped 62% to $40M.
- Trailing-twelve-month free cash flow rose 82% to $1.72B (10.7% of revenue), though quarterly free cash flow was negative at $(14)M on $1.12B of capex.
- Total cash returned to shareholders over the trailing twelve months reached $6.43B (up 34%), including $4.85B in dividends and $1.58B in stock repurchases; quarterly dividends declared were $1.36 per share versus $1.30 a year earlier.
- Q2 2025 guidance calls for revenue of $4.17–4.53B and EPS of $1.21–1.47, with an effective tax rate of about 12–13%.
- Cash and short-term investments declined to $5.0B from $10.4B a year earlier, while inventories rose 15% to $4.69B and long-term debt stood at $12.85B.
03—Questions
Frequently Asked Questions
How much of the EPS growth was driven by underlying operations versus one-time or tax items?
The company said EPS included a 5-cent benefit not in its original guidance. The income statement shows a Q1 2025 discrete tax benefit of $69M, versus a $12M discrete expense in Q1 2024. Operating profit grew only 3% ($1.324B vs. $1.286B), and that comparison benefited from a $124M restructuring credit in Q1 2024. Underlying operating growth was therefore more modest than headline EPS growth suggests.
Why did free cash flow improve so sharply on a trailing basis while operating cash flow declined?
Trailing-twelve-month operating cash flow fell 2% to $6.15B, but capital expenditures decreased from $5.34B to $4.70B, and the company recorded $260M of CHIPS Act incentive proceeds in Q1 2025. Free cash flow is defined as operating cash flow less capex plus CHIPS Act proceeds, so lower capex and the incentive inflow drove the 82% increase to $1.72B. Management also cited a $588M CHIPS Act investment tax credit benefit within operating cash flow over the trailing twelve months, which is a non-recurring type of support investors should consider.
Are shareholder returns sustainable given current cash generation?
Trailing-twelve-month cash returns of $6.43B exceeded trailing free cash flow of $1.72B by a wide margin. The gap was funded from balance-sheet cash and short-term investments, which fell to $5.0B from $10.4B a year earlier. Dividends of $4.85B are covered by operating cash flow, but sustaining both the dividend and elevated buybacks depends on capex normalizing and on a recovery in cash generation. Quarterly free cash flow was negative in Q1 2025, which reinforces this concern.
What does the segment mix reveal about the business trajectory?
Analog drove growth, with revenue up 13% and operating profit up 20% to $1.21B, accounting for most of the company's operating profit. Embedded Processing revenue fell 1% and its operating profit dropped 62% to $40M, indicating margin pressure in that segment. The 'Other' category grew revenue 23% but its operating profit fell 55%, partly due to the absence of prior-year restructuring benefits. Investors should watch whether Embedded Processing margins recover.
What is the outlook for the coming quarter?
Management guided Q2 2025 revenue to $4.17–4.53B and EPS to $1.21–1.47, and lowered its expected effective tax rate to about 12–13%. The guidance range is wide, and the EPS range's low end is below the Q1 2025 result of $1.28, which reflects both the tax benefit that won't recur at the same level and the revenue range. Management's forward-looking statements also flag risks including tariffs, customer inventory adjustments, and competitive pricing pressure.
04—Continue